Distribution of NTPDase5 and NTPDase6 and the regulation of P2Y receptor signalling in the rat cochlea.
Membrane-bound ectonucleoside triphosphate diphosphohydrolases (E-NTPDases) in the inner ear regulate complex extracellular purinergic type-2 (P2) receptor signalling pathways through hydrolysis of extracellular nucleoside 5'-triphosphates and diphosphates. This study investigated the distribution of NTPDase5 and NTPDase6, two intracellular members of the E-NTPDase family, and linked this to regulation of P2 receptor signalling in the adult rat cochlea. These extracellular ectonucleotidases preferentially hydrolyse nucleoside 5'-diphosphates such as UDP and GDP. Expression of both enzymes at mRNA and protein level was detected in cochlear tissues and there was in vivo release of soluble NTPDase5 and 6 into cochlear fluids. Strong NTPDase5 immunostaining was found in the spiral ganglion neurones and supporting Deiters' cells of the organ of Corti, while NTPDase6 was confined to the inner hair cells. Upregulation of NTPDase5 after exposure to loud sound indicates a dynamic role for NTPDase5 in cochlear response to stress, whereas NTPDase6 may have more limited extracellular roles. Noise-induced upregulation of co-localised UDP-preferring P2Y(6) receptors in the spiral ganglion neurons further supports the involvement of NTPDase5 in regulation of P2Y receptor signalling. Noise stress also induced P2Y(14) (UDP- and UDP-glucose preferring) receptor expression in the root processes of the outer sulcus cells, but this was not associated with localization of the E-NTPDases.
O'Keeffe
Mary G
MG
Thorne
Peter R
PR
Housley
Gary D
GD
Robson
Simon C
SC
Vlajkovic
Srdjan M
SM
Biochemistry. 2000 Oct 24;39(42):12924-8
11041857
EMBO J. 1999 Jun 15;18(12):3282-92
10369669
Histochem Cell Biol. 2006 Apr;125(4):327-36
16195889
Biochem Pharmacol. 2001 Jul 15;62(2):219-24
11389881
J Comp Neurol. 2005 Aug 22;489(2):180-94
15983998
Biochem J. 2000 Nov 1;351 Pt 3:639-47
11042118
Purinergic Signal. 2006 Jun;2(2):409-30
18404480
J Cell Physiol. 2007 Oct;213(1):54-64
17620283
Audiol Neurootol. 2003 Jan-Feb;8(1):28-37
12566690
J Biol Chem. 1999 Jul 16;274(29):20064-7
10400613
Mol Carcinog. 2002 Apr;33(4):219-27
11933075
Neuroreport. 2003 May 6;14(6):817-23
12858039
Methods. 2001 Dec;25(4):402-8
11846609
Neuroscience. 2006 Oct 13;142(2):425-35
16887274
Cell Calcium. 2007 Jan;41(1):77-86
16828497
Int J Oncol. 2006 Mar;28(3):595-604
16465363
Neuroreport. 1998 May 11;9(7):1559-65
9631467
Mol Pharmacol. 2004 Sep;66(3):468-77
15322238
Trends Neurosci. 2009 Mar;32(3):128-41
19232752
Mol Carcinog. 2000 Mar;27(3):229-36
10708485
Cell Tissue Res. 2007 Jun;328(3):461-71
17285327
Trends Pharmacol Sci. 1997 Mar;18(3):83-6
9133777
J Neurophysiol. 1999 Dec;82(6):3307-15
10601462
Hear Res. 1998 Mar;117(1-2):71-80
9580435
Int J Oncol. 2001 Dec;19(6):1249-54
11713596
Biochemistry. 2003 Oct 14;42(40):11726-35
14529283
Purinergic Signal. 2005 Jun;1(2):193-204
18404504
J Biol Chem. 2000 Nov 3;275(44):34041-5
10948193
J Neurochem. 2007 Sep;102(5):1447-1458
17697046
J Biol Chem. 2002 Oct 4;277(40):36978-86
12167635
Neuroscience. 2006;138(2):421-32
16414200
Mol Carcinog. 2002 Dec;35(4):186-95
12489110
J Neurophysiol. 2002 Jun;87(6):2734-40
12037175
Brain Res. 2006 Jan 27;1070(1):71-6
16405924
Biochim Biophys Acta. 2005 Mar 14;1747(2):251-9
15698960
Int J Oncol. 2004 Oct;25(4):821-30
15375529
Brain Res. 1998 Sep 14;805(1-2):181-90
9733963
Acta Otolaryngol. 2001 Jan;121(1):10-5
11270486
Hear Res. 2002 Aug;170(1-2):127-38
12208547
Curr Biol. 2004 Mar 23;14(6):526-9
15043820
Purinergic Signal. 2007 Sep;3(4):389-98
18404452
Biochemistry. 2000 Oct 24;39(42):12916-23
11041856
Neuroscience. 2004;126(3):763-73
15183524
Brain Res. 2006 Aug 9;1104(1):55-63
16815340
J Assoc Res Otolaryngol. 2004 Mar;5(1):58-65
14976588
Br J Pharmacol. 2000 Mar;129(5):921-6
10696091
Genomics. 1998 Jun 15;50(3):357-67
9676430
Histochem Cell Biol. 2003 Mar;119(3):247-56
12649740